Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) confirmed by imaging scans, at an early to intermediate or locally advanced stage (classified as BCLC stage 0, A, B, or C)
- People whose case has been reviewed by a team of specialists (a multidisciplinary tumor board) who have approved them for a specific liver treatment called Y90 radioembolization (a procedure that delivers radiation directly to liver tumors through the blood vessels)
Who may not be able to join:
- People who are not considered suitable candidates for the Y90 radioembolization procedure
- People who have already had surgery or a tumor-destroying treatment (called ablation) on the specific tumors being targeted in this trial
- People who are unable to attend the follow-up appointments required for their medical care and for the research study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sirish Kishore, MD, VA Palo Alto Health Care System
Phone: 650-493-5000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Circulating Tumor Cell (CTC); CTA imaging
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.